Research Analysts Issue Forecasts for Enovix FY2026 Earnings

Enovix Co. (NASDAQ:ENVXFree Report) – Cantor Fitzgerald issued their FY2026 EPS estimates for Enovix in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst D. Soderberg anticipates that the company will earn ($0.97) per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $30.00 price objective on the stock. The consensus estimate for Enovix’s current full-year earnings is ($1.01) per share.

Several other analysts also recently issued reports on ENVX. TD Securities reduced their price target on shares of Enovix from $10.00 to $7.00 and set a “hold” rating on the stock in a report on Thursday, May 1st. Benchmark reduced their price target on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, April 15th. B. Riley reduced their price target on shares of Enovix from $17.00 to $12.00 and set a “buy” rating on the stock in a report on Tuesday, April 29th. Craig Hallum reduced their price target on shares of Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Enovix from $10.00 to $9.00 and set an “overweight” rating on the stock in a report on Thursday, May 1st. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $17.27.

Read Our Latest Research Report on Enovix

Enovix Trading Up 0.7%

Shares of ENVX opened at $8.68 on Tuesday. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The firm’s 50-day moving average is $7.06 and its two-hundred day moving average is $8.94. Enovix has a twelve month low of $5.27 and a twelve month high of $18.68. The firm has a market capitalization of $1.67 billion, a P/E ratio of -5.99 and a beta of 2.00.

Institutional Trading of Enovix

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Enovix by 15.1% in the 4th quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company’s stock worth $171,458,000 after acquiring an additional 2,063,631 shares during the period. Electron Capital Partners LLC boosted its holdings in shares of Enovix by 18.6% in the 1st quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company’s stock valued at $49,272,000 after purchasing an additional 1,054,029 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Enovix by 6.6% in the 4th quarter. Geode Capital Management LLC now owns 3,818,827 shares of the company’s stock valued at $41,520,000 after purchasing an additional 235,142 shares during the last quarter. Driehaus Capital Management LLC boosted its holdings in shares of Enovix by 1.8% in the 1st quarter. Driehaus Capital Management LLC now owns 2,323,612 shares of the company’s stock valued at $17,055,000 after purchasing an additional 41,559 shares during the last quarter. Finally, Fred Alger Management LLC boosted its holdings in shares of Enovix by 21.5% in the 1st quarter. Fred Alger Management LLC now owns 2,233,446 shares of the company’s stock valued at $16,393,000 after purchasing an additional 394,532 shares during the last quarter. 50.92% of the stock is owned by hedge funds and other institutional investors.

About Enovix

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Earnings History and Estimates for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.